Cargando…

Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression

Aberrant integration of newborn hippocampal granule cells is hypothesized to contribute to the development of temporal lobe epilepsy. To test this hypothesis, we used a diphtheria toxin receptor expression system to selectively ablate these cells from the epileptic mouse brain. Epileptogenesis was i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosford, Bethany E., Rowley, Shane, Liska, John P., Danzer, Steve C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740143/
https://www.ncbi.nlm.nih.gov/pubmed/29269775
http://dx.doi.org/10.1038/s41598-017-18237-6
_version_ 1783287990871654400
author Hosford, Bethany E.
Rowley, Shane
Liska, John P.
Danzer, Steve C.
author_facet Hosford, Bethany E.
Rowley, Shane
Liska, John P.
Danzer, Steve C.
author_sort Hosford, Bethany E.
collection PubMed
description Aberrant integration of newborn hippocampal granule cells is hypothesized to contribute to the development of temporal lobe epilepsy. To test this hypothesis, we used a diphtheria toxin receptor expression system to selectively ablate these cells from the epileptic mouse brain. Epileptogenesis was initiated using the pilocarpine status epilepticus model in male and female mice. Continuous EEG monitoring was begun 2–3 months after pilocarpine treatment. Four weeks into the EEG recording period, at a time when spontaneous seizures were frequent, mice were treated with diphtheria toxin to ablate peri-insult generated newborn granule cells, which were born in the weeks just before and after pilocarpine treatment. EEG monitoring continued for another month after cell ablation. Ablation halted epilepsy progression relative to untreated epileptic mice; the latter showing a significant and dramatic 300% increase in seizure frequency. This increase was prevented in treated mice. Ablation did not, however, cause an immediate reduction in seizures, suggesting that peri-insult generated cells mediate epileptogenesis, but that seizures per se are initiated elsewhere in the circuit. These findings demonstrate that targeted ablation of newborn granule cells can produce a striking improvement in disease course, and that the treatment can be effective when applied months after disease onset.
format Online
Article
Text
id pubmed-5740143
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57401432018-01-03 Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression Hosford, Bethany E. Rowley, Shane Liska, John P. Danzer, Steve C. Sci Rep Article Aberrant integration of newborn hippocampal granule cells is hypothesized to contribute to the development of temporal lobe epilepsy. To test this hypothesis, we used a diphtheria toxin receptor expression system to selectively ablate these cells from the epileptic mouse brain. Epileptogenesis was initiated using the pilocarpine status epilepticus model in male and female mice. Continuous EEG monitoring was begun 2–3 months after pilocarpine treatment. Four weeks into the EEG recording period, at a time when spontaneous seizures were frequent, mice were treated with diphtheria toxin to ablate peri-insult generated newborn granule cells, which were born in the weeks just before and after pilocarpine treatment. EEG monitoring continued for another month after cell ablation. Ablation halted epilepsy progression relative to untreated epileptic mice; the latter showing a significant and dramatic 300% increase in seizure frequency. This increase was prevented in treated mice. Ablation did not, however, cause an immediate reduction in seizures, suggesting that peri-insult generated cells mediate epileptogenesis, but that seizures per se are initiated elsewhere in the circuit. These findings demonstrate that targeted ablation of newborn granule cells can produce a striking improvement in disease course, and that the treatment can be effective when applied months after disease onset. Nature Publishing Group UK 2017-12-21 /pmc/articles/PMC5740143/ /pubmed/29269775 http://dx.doi.org/10.1038/s41598-017-18237-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Hosford, Bethany E.
Rowley, Shane
Liska, John P.
Danzer, Steve C.
Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression
title Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression
title_full Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression
title_fullStr Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression
title_full_unstemmed Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression
title_short Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression
title_sort ablation of peri-insult generated granule cells after epilepsy onset halts disease progression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740143/
https://www.ncbi.nlm.nih.gov/pubmed/29269775
http://dx.doi.org/10.1038/s41598-017-18237-6
work_keys_str_mv AT hosfordbethanye ablationofperiinsultgeneratedgranulecellsafterepilepsyonsethaltsdiseaseprogression
AT rowleyshane ablationofperiinsultgeneratedgranulecellsafterepilepsyonsethaltsdiseaseprogression
AT liskajohnp ablationofperiinsultgeneratedgranulecellsafterepilepsyonsethaltsdiseaseprogression
AT danzerstevec ablationofperiinsultgeneratedgranulecellsafterepilepsyonsethaltsdiseaseprogression